Expression of matrix metalloproteinase-9 in myocardium of mice with viral myocarditis

YANG Min; CHEN Chun-Yuan; CAI Zi-Li; CHEN Bai-Lin; CHENG Liang; LI Hui

PDF(1530 KB)

Chinese Journal of Contemporary Pediatrics ›› 2011, Vol. 13 ›› Issue (8) : 669-673.

EXPERIMENTAL RESEARCH

Expression of matrix metalloproteinase-9 in myocardium of mice with viral myocarditis

YANG Min, CHEN Chun-Yuan, CAI Zi-Li, CHEN Bai-Lin, CHENG Liang, LI Hui

Author information +

History +

Abstract

OBJECTIVE: To investigate the dynamic changes of expression of matrix metalloproteinases-9 in myocardium of mice with viral myocarditis (VMC) and its significance in the pathogenesis of viral myocarditis. METHODS: VMC model was prepared by an injection of CVB3 in BALB/C mice. The mice receiving an injection of culture solution without virus were used as the control group. Cardiac tissues were obtained 7, 14, 21 and 28 days after injection and made into paraffin sections. Myocardial histopathologic changes were observed by hematoxylin-eosin staining and Masson staining. The expression of MMP-9, type I collagen and type III collagen in cardiac tissues were quantified by SABC immunohistochemical method. RESULTS: The expression of MMP-9 in the VMC model group was observed on the 7th day, reached a peak on the 14th day, and was significantly higher than that in the control group at all time points (P<0.05). Compared with the control group, the expression of type I collagen in the VMC model group was up-regulated on the 21st day and reached a peak on the 28th day (P<0.05). The expression of type III collagen in the VMC model group was significantly higher than that in the control group on the 28th day (P<0.05). The expression of MMP-9 was positively correlated with myocardial histopathologic scores (r=0.832, P<0.05) and negatively correlated with type I collagen expression (r=-0.791, P<0.05). CONCLUSIONS: MMP-9 is over-expressed at the early stage in VMC mice, and participates in the pathological process of VMC through mediating the degradation metabolism of type I collagen. It may be an important factor that leads to myocardial collagen remodeling and myocardial fibrosis.

Key words

Viral myocarditis / Matrix metalloproteinases-9 / Type I collagen / Type III collagen / Mice

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

YANG Min, CHEN Chun-Yuan, CAI Zi-Li, CHEN Bai-Lin, CHENG Liang, LI Hui. Expression of matrix metalloproteinase-9 in myocardium of mice with viral myocarditis[J]. Chinese Journal of Contemporary Pediatrics. 2011, 13(8): 669-673

References

［1］Maisch B, Alter P, Karatolius K, Ruppert V, Pankuweit S. The heart in cases of viral, bacterial and parasitic infections［J］. Internist(Berl), 2007, 48(3): 255-267.

［2］Jeserich M, Konstantinides S, Pavlik G, Bode C, Geibel A. Non-invasive imaging in the diagnosis of acute viral myocarditis［J］. Clin Res Cardiol, 2009, 98(12):753-763.

［3］蔡小芳，麦根荣，徐之良. 小儿扩张型心肌病与病毒性心肌炎的临床研究［J］. 中国当代儿科杂志，2004，6(4): 325-327.

［4］Szalay G, Sauter M, Haberland M, Zuegel U, Steinmeyer A, Kandolf R, et al. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host［J］. Circ Res, 2009, 104(7):851-859.

［5］Leipner C, Grün K, Müller A, Buchdunger E, Borsi L, Kosmehl H, et al. Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis［J］. Cardiovasc Res, 2008, 79(1): 118-126.

［6］Heymans S, Pauschinger M, De Palma A, Kallwellis-Opara A, Rutschow S, Swinnen M, et al. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis［J］. Circulation, 2006, 114(6): 565-573.

［7］Nelissen I, Martens E, Van den Steen PE, Proost P, Ronsse I, Opdenakker G. Gelatinase B/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy［J］. Brain, 2003, 126(Pt 6): 1371-1381.

［8］Li J, Schwimmbeck PL, Tschope C, Leschka S, Husmann L, Rutschow S, et al. Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction［J］. Cardiovas Res, 2002, 56(2): 235-247.

［9］Rezkalla S, Kloner RA, Khatib G, Smith FE, Khatib R. Effect of metoprolol on the acute phase of coxsackievirus B3 murine myocarditis［J］. J Am Coll Cardiol, 1988, 12(2): 412-414.

［10］孟晓慧，汪翼. 基质金属蛋白酶与小儿心血管疾病的关系［J］. 国外医学儿科学分册，2003，30(3): 144-146.

［11］Meng XH, Wang Y, Zhuang JX, Han XZ, Chen Y, Jin YP, et al. Dynamic changes in myocardial matrix metalloproteinase activity in mice with viral myocarditis［J］. Chin Med J (Engl), 2004, 117(8): 1195-1199.

［12］Sch-nbeck U, Mach F, Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing［J］. J Immunol, 1998, 161(7): 3340-3346.

［13］Higuchi H, Hara M, Yamamoto K, Miyamoto T, Kinoshita M, Yamada T, et al. Mast cells play a critical role in the pathogenesis of viral myocarditis［J］. Circulation, 2008, 118(4): 363-372.

［14］Kim JY, Kim WJ, Kim H, Suk K, Lee WH. The stimulation of CD147 induces MMP-9 expression through ERK and NF-kappaB in macrophages: implication for atherosclerosis［J］. Immune Netw, 2009, 9(3): 90-97.

［15］张小佛，于小华，郭富强，李双杰. 病毒性心肌炎患儿血清巨噬细胞移动抑制因子、肿瘤坏死因子-α、白细胞介素-1β表达及其意义［J］. 实用儿科临床杂志，2008，23(1)：35-36.

［16］孟晓慧，汪翼，于永慧，陈瑶，马沛然. 病毒性心肌炎小鼠血管紧张素的改变与心肌胶原的关系［J］. 医学临床研究，2004，21(4): 340-344.